Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β-blockers in SURVIVE†

AIMS: Many chronic heart failure (CHF) patients take β-blockers. When such patients are hospitalized for decompensation, it remains unclear how ongoing β-blocker treatment will affect outcomes of acute inotrope therapy. We aimed to assess outcomes of SURVIVE patients who were on β-blocker therapy be...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Mebazaa, Alexandre, Nieminen, Markku S., Filippatos, Gerasimos S., Cleland, John G., Salon, Jeffrey E., Thakkar, Roopal, Padley, Robert J., Huang, Bidan, Cohen-Solal, Alain
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2009
Pynciau:
Treatment
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2645051/
https://ncbi.nlm.nih.gov/pubmed/19158152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurjhf/hfn045
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg